Drug Research
ViGeneron and WuXi AppTec Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy
ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. (WuXi ATU), a leading Contract, Testing, Development and Manufacturing Organization (CTDMO), announced a strategic partnership to accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy...
Drug Research
UK Approves Pfizer COVID-19 Vaccine: Expect A Next Week Roll-Out
In a historic occurrence which has taken the world by storm, the UK Government has officially approved the usage of Pfizer’s coronavirus vaccine. This move may bring a lot of intensity to other countries and their respective regulators too....
Drug Research
Sterling announces strategic investment in ADC Biotechnology
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions (Sterling), has announced a new strategic partnership with ADC Biotechnology (ADC Bio), a UK based biotechnology company specialising in antibody drug conjugates.
The partnership will see Sterling make a significant...
Drug Research
Moderna Announces Amendment to Current Supply Agreement with UK Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19
Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the UK government for an additional 2 million doses of mRNA-1273,...
Drug Research
Samsung Biologics breaks ground on Super Plant, the world’s largest and most innovative bio-manufacturing facility
Samsung Biologics officially began construction of its Plant 4 in Incheon, South Korea. Dubbed the “Super Plant,” the new, multi-story 238,000-square-meter construction will be the world’s largest biopharmaceutical manufacturing facility of its kind boasting 256,000 liters total manufacturing capacity.
In...
Drug Research
CureVac and WACKER Sign Manufacturing Contract for CureVac’s COVID-19 Vaccine Candidate
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Wacker Chemie AG announced that they had signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV. Under...
Drug Research
Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement
Eli Lilly and Company and Precision BioSciences, Inc. announced a research collaboration and exclusive license agreement to utilize Precision's proprietary ARCUS® genome editing platform for the research and development of potential in vivo therapies for genetic disorders, with an...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
